Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification: higher contrast uptake associated with response and better prognosis

Abstract Background To explore the prognostic value of serial dynamic contrast-enhanced (DCE) MRI in patients with advanced pulmonary adenocarcinoma undergoing first-line therapy with either tyrosine-kinase inhibitors (TKI) or platinum-based chemotherapy (PBC). Methods Patients underwent baseline (d...

Full description

Bibliographic Details
Main Authors: Stephan Rheinheimer, Petros Christopoulos, Stella Erdmann, Julia Saupe, Heiko Golpon, Jens Vogel-Claussen, Julien Dinkel, Michael Thomas, Claus Peter Heussel, Hans-Ulrich Kauczor, Gudula Heussel
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Medical Imaging
Subjects:
Online Access:https://doi.org/10.1186/s12880-022-00943-x